Close

More on ACOR

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-139.7% Growth)
- Ratings (2.3 Score)
- Holders
- Event Driven Deals

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (11/7/23 *Est.)
- M&A (1/26/16 *Est)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

ACOR Cash Flow Statement

Click line-items for a historical chart and %
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash provided by operating activities:
Share-based compensation expense 27.39M
Amortization of net premiums and discounts on short-term investments
Amortization of revenue interest issuance cost 0
Depreciation and amortization expense 15.78M
Gain on put/call liability
Changes in assets and liabilities:
Increase in accounts receivable -17.02M
Increase in prepaid expenses and other current assets 5.82M
Increase in inventory held by the Company -4.46M
Decrease in inventory held by others
Decrease in non-current portion of deferred cost of license revenue 476K
Increase in other assets 25K
Decrease in accounts payable, accrued expenses, other current liabilities 9.61M
Increase in revenue interest liability interest payable 0
Decrease in current portion of deferred license revenue
Decrease in non-current portion of deferred license revenue
Increase (decrease) in deferred product revenue-Zanaflex tablets 0
Decrease in deferred product revenue-Zanaflex Capsules
Net cash used in operating activities
Cash flows from investing activities:
Purchases of property and equipment -4.63M
Purchases of intangible assets -482K
Purchases of short-term investments -40.21M
Proceeds from maturities of short-term investments 239.97M
Net cash provided by investing activities
Cash flows from financing activities:
Proceeds from issuance of common stock and option exercises 74.67M
Repayments of revenue interest liability -41K
Net cash provided by financing activities
Net increase in cash and cash equivalents -25.26M
Cash and cash equivalents at beginning of period 153.2M
Cash and cash equivalents at end of period 127.94M
Supplemental disclosure:
Cash paid for interest 3.04M

Entities mentioned with ACOR

View All Entities